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Purpose: To identify risk factors for cataracts treated surgically in postmenopausal women.
Design: Population-based, prospective cohort study.
Participants: A total of 1 312 051 postmenopausal women in the UK Million Women Study, aged 56 years on
average (standard deviation [SD], 4.8), without previous cataract surgery, hospital admission with cataracts, or
cancer at baseline, were followed for cataracts treated surgically.
Methods: Cox regression was used to calculate adjusted relative risks (RRs) for cataract surgery by lifestyle
factors, treatment for diabetes, reproductive history, and use of hormonal therapies.
Main Outcome Measures: Cataract surgery identiﬁed by linkage to central National Health Service (NHS)
records for inpatient and day-patient admissions (Hospital Episode Statistics for England and Scottish Morbidity
Records in Scotland).
Results: Overall, 89 343 women underwent cataract surgery during an average of 11 (SD, 3) years of follow-
up. Women with diabetes were at greatest risk (diabetes vs. no diabetes RR, 2.90; 95% conﬁdence interval [CI],
2.82e2.97). Other factors associated with an increased risk of cataract surgery were current smoking (current
smokers of 15 cigarettes/day vs. never smokers RR, 1.26; 95% CI, 1.23e1.30) and obesity (body mass index
[BMI] 30 vs. <25 kg/m2; RR, 1.12; 95% CI, 1.10e1.14).
Conclusions: Diabetes, smoking, and obesity were risk factors for cataract surgery. Alcohol use, physical
activity, reproductive history, and use of hormonal therapies had little, if any, association with cataract surgery
risk. Ophthalmology 2016;123:1704-1710 ª 2016 by the American Academy of Ophthalmology. This is an open
access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Cataract is the second leading cause of partial sight and
blindness in the United Kingdom, exceeded only by age-
related macular degeneration.1 Identifying potential risk
factors for cataract is important given that the only
treatment for cataract is the surgical removal of the lens.
The most important risk factor for cataract formation is
age.2 Other risk factors that have been identiﬁed are
diabetes, smoking, ultraviolet (UV) light, and steroid
use,2e7 but there is less evidence on the role of factors
such as body mass index (BMI), physical activity, repro-
ductive history, use of hormonal therapies, and alcohol
consumption.4,8e11
Cataract surgery is the most common surgical procedure
in the National Health Service (NHS) in England, with
more than 340 000 operations carried out in 2013
and 2014.12 Rates of cataract surgery in England have
increased rapidly since 1990 because of the widespread
uptake of phacoemulsiﬁcation and day case surgery.11
For people aged more than 60 years, rates are higher
for women compared with men.11 It has been proposed
that this higher rate of surgery results from higher
incidence of cataracts in postmenopausal women
compared with men of a similar age because of hormonal
differences between men and women.13e15 However,
epidemiologic evidence on the relationship between1704  2016 by the American Academy of Ophthalmology
This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/). Published by Elsevier Inc.cataracts and reproductive and hormonal factors, including
use of hormone therapy (HT) for menopause, is limited and
inconsistent.4,16,17
In a large cohort of postmenopausal women from the
United Kingdom, with virtually complete long-term follow-
up for surgical procedures through linkage to hospital
records, we have examined potential risk factors for cata-
racts treated surgically, including treatment for diabetes,
lifestyle, and reproductive and hormonal factors.
Methods
Data Collection and Deﬁnitions
The Million Women Study is a population-based prospective
study of women in the United Kingdom. Details of the design
and methods of the study have been described.18 Brieﬂy, 1.3
million women aged 50 to 64 years were invited for breast
cancer screening at NHS clinics in England and Scotland
and were recruited to the study between 1996 and 2001 by
completing a questionnaire, which included questions on various
socioeconomic, lifestyle, reproductive, and hormonal factors.
The respondents gave written consent to participate and for
follow-up though their NHS medical records; ethical approval
was provided by the Oxford and Anglia Multi-Centre Research
Ethics Committee. Study questionnaires and details of thehttp://dx.doi.org/10.1016/j.ophtha.2016.04.037
ISSN 0161-6420/16
Floud et al  Risk Factors for Cataract Surgerystudy data and access policies can be viewed on the website
(www.millionwomenstudy.org).
Follow-up
Individuals in the study are linked by their unique NHS identiﬁ-
cation number to NHS Central Registers, through which they are
followed for emigration, death, and cancer registration, and to NHS
hospital admissions databases: Hospital Episode Statistics for
England and Scottish Morbidity Records for Scotland. The data-
bases include information on both inpatient stays and day-case
admissions (e.g., for surgical procedures). Follow-up is 99%
complete; only 18 970 women (1%) have been lost to follow-up in
the entire cohort, and they have been included in analyses up to the
date of loss to follow-up. Information on the date and type of
procedures associated with each hospital admission is provided,
coded to the Ofﬁce of Population Censuses and Survey’s classiﬁ-
cation of surgical operations and procedures, fourth revision
(OPCS-4). Linked data for England are provided to the cohort
through the Health and Social Care Information Centre and the
Ofﬁce for National Statistics, and for Scotland by the NHS Infor-
mation Services Division.
Statistical Analysis
Analyses were restricted to postmenopausal women. Those who
reported at recruitment that they had experienced natural menopause
(49%) or who had undergone a bilateral oophorectomy (6%) were
deﬁned as postmenopausal and included in follow-up from
recruitment. Women who were premenopausal, perimenopausal, or
of unknown menopausal status at recruitment were assumed to be
postmenopausal after they reached the age of 55 years and were
included in follow-up from age 55 years, because 96% of women in
this cohort with a known age at natural menopause were post-
menopausal by that age.19 Women were excluded from the analysis
if their linked hospital records showed that they had previous
cataract surgery or were admitted to a hospital with cataracts
before recruitment, or if the cancer registration records showed
that they had preexisting cancer, with the exception of
nonmelanoma skin cancer. For these analyses, cases were deﬁned
as the ﬁrst hospital record (day-case or overnight admission) of
cataract surgery (OPCS-4:C71eC75) occurring after recruitment
into the study. Women were followed until the date of ﬁrst
cataract surgery, date of death, or the end of the hospital
admissions follow-up period (March 2011 for England and
December 2008 for Scotland).
Cox proportional hazards models were used to estimate relative
risks (RRs) and 95% conﬁdence intervals (CIs) for cataracts treated
surgically according to area deprivation (quintiles, based on the
Townsend index, a score incorporating census area data for
employment, car ownership, home ownership, and household
overcrowding20), educational qualiﬁcations (“tertiary” [college or
university], “secondary” [A levels or O levels, usually obtained at
age 18 and 16 years respectively], “technical” [nursing, teaching,
clerical, or commercial], “no qualiﬁcations”), smoking status
(never, past, current <15 cigarettes per day, current 15 cigarettes
per day), BMI (<25, 25e29, 30 kg/m2), alcohol intake
(<2, 2e14, 15 units per week [unit w10 g alcohol]), strenuous
physical activity (rarely/never, some), self-reported treatment for
diabetes (yes, no), age at menarche (12, 13, 14,15 years), parity
(nulliparous, parous), number of children (1, 2, 3, 4), duration of
oral contraceptive use (<5,5 years), and use of HT for menopause
(never, ever). All variables were as reported at recruitment. The
underlying time variable was attained age, and all analyses were
routinely stratiﬁed for the recruitment region (10 geographic re-
gions). For RRs reported as multiply adjusted, analyses weremutually adjusted for all other potential risk factors using the cate-
gories described (except for parity, which was adjusted for using 2
categories: parous/nulliparous).Missing values of adjustment factors
(<6% for all variables) were included as a separate category.
In an additional analysis, we investigated the association
between cataracts treated surgically and the 2 main types of HT:
estrogen-only or estrogen-progestogen. Women reporting current
use were classiﬁed according to most recent type reported, and
analyses accounted for changes in use during follow-up. Women
were initially classiﬁed using information provided at recruitment,
and those who provided updated information on HT use on the
second study questionnaire (on average 3 years after recruitment)
were then reclassiﬁed using this updated information. For all
women, the period of follow-up was censored at 48 months after
last report of HT use. All analyses used Stata 14.1 (StataCorp LP,
College Station, TX).
Results
After excluding 4150 women with a hospital record of cataract
surgery before recruitment, 166 women with a previous hospital
admission diagnosis of cataract, and 44 781 women with preex-
isting cancer, these analyses included prospective data on cataract
surgery in 1 312 051 postmenopausal women. Over a mean follow-
up period of 10.7 years (standard deviation [SD], 2.6 years) per
woman, 89 343 women (6.8%) underwent cataract surgery, cor-
responding to an incidence rate of 6.38 (95% CI, 6.33e6.41) per
1000 person-years.
Table 1 shows the characteristics of the study population at
baseline. Mean age at recruitment was 56.1 years (SD, 4.8
years); 21% reported that they were current smokers; mean BMI
was 26.2 kg/m2 (SD, 4.7); 59% reported ever using oral
contraceptives; and 34% were currently using HT.
Table 2 shows the RR of cataracts treated surgically by various
categories of socioeconomic and lifestyle factors, as well as
treatment for diabetes. Overall, 2% (31 612) of the women in the
study population reported being treated for diabetes, and this was
the strongest risk factor for cataracts treated surgically (multiply
adjusted RR for diabetes vs. no diabetes, 2.90, 95% CI,
2.82e2.97). Both past and current smoking at recruitment were
associated with increased risk of cataracts treated surgically, with
multiply adjusted RRs compared with never smokers of 1.10 (95%
CI, 1.08e1.12) in past smokers, 1.12 (95% CI, 1.09e1.14) in
current smokers of less than 15 cigarettes per day, and 1.26 (95%
CI, 1.23e1.30) in current smokers of 15 or more cigarettes per
day. Obesity was associated with a small increase in risk of
cataracts treated surgically; this association was stronger in the
minimally adjusted analysis (adjusted for age and region only) but
remained signiﬁcant after adjustment for other factors, including
treatment for diabetes (multiply adjusted RR, 1.12; 95% CI,
1.10e1.14 for women with BMI 30 kg/m2 compared with <25
kg/m2). In analyses restricted to those not reporting treatment for
diabetes, the association was similar (multiply adjusted RR, 1.15;
95% CI, 1.12e1.17 for women with BMI 30 kg/m2 compared
with <25 kg/m2).
Women who reported doing some strenuous physical activity
every week had a slightly lower risk of cataracts treated surgically
compared with women who reported rarely or never engaging in
strenuous physical activity (multiply adjusted RR, 0.90; 95% CI,
0.88e0.91). Alcohol consumption of 2 units or more per week was
weakly associated after adjustment, with a slightly lower risk of1705
Table 1. Baseline Characteristics of Women Who Subsequently Underwent Cataract Surgery and of All Women Included in the Analysis
Characteristics at Baseline Women Who Underwent Cataract Surgery during Follow-up All Women
No. of women 89 343 1 312 051
Mean age at recruitment, yrs (SD) 59.5 (5.1) 56.1 (4.8)
Percentage in most deprived quintile (n) 23.3 (20 654) 19.9 (258 798)
Percentage with no qualiﬁcations (n) 50.5 (43 657) 43.9 (561 001)
Percentage current smokers (n) 19.4 (16 177) 20.5 (253 411)
Mean BMI, kg/m2 (SD) 26.7 (4.9) 26.2 (4.7)
Mean alcohol intake, units/wk (SD) 3.5 (5.0) 4.1 (5.3)
Percentage rarely/never strenuously active (n) 55.2 (46 960) 48.7 (614 944)
Percentage treated for diabetes (n) 7.5 (6671) 2.4 (31 612)
Mean parity (SD) 2.2 (1.4) 2.1 (1.2)
Mean age at menarche, yrs (SD) 13.1 (1.6) 13.0 (1.6)
Percentage ever used oral contraceptives (n) 47.7 (41 916) 59.3 (769 595)
Percentage current user of HT (n) 29.5 (25 934) 33.5 (434 135)
BMI ¼ body mass index; HT ¼ hormone therapy; SD ¼ standard deviation.
Ophthalmology Volume 123, Number 8, August 2016cataracts treated surgically compared with consumption of less than
2 units per week, but there was no suggestion of a trend by amount
of alcohol.
In minimally adjusted analyses (adjusted for age and region
only) both deprivation and lack of educational qualiﬁcations wereTable 2. Relative Risk of Cataracts Treated Surgically Associated wit
Population at Risk Ca
Area deprivation
1: least deprived 262 316 15
2 261 515 16
3 259 789 17
4 260 093 18
5: most deprived 258 798 20
Educational qualiﬁcations
Tertiary 167 904 9
Secondary 333 445 19
Technical 215 692 13
No qualiﬁcations 561 001 43
Smoking
Never 630 939 42
Past 350 569 25
Current <15 129 961 8
Current 15þ 123 450 7
BMI
<25 kg/m2 575 282 35
25e29 kg/m2 445 121 30
30þ kg/m2 223 065 17
Alcohol (units per week)
<2 557 045 43
2e14 679 389 41
15þ 65 314 3
Strenuous physical activity
Rarely/never 614 944 46
Some 647 872 38
Treatment for diabetes
No 1 279 660 82
Yes 31 612 6
BMI ¼ body mass index; CI ¼ conﬁdence interval; RR ¼ relative risk.
*Estimates of RR are adjusted by age and region of residence.
yEstimates of RR are adjusted by age and region of residence plus deprivation,
activity, treatment for diabetes, age at menarche, parity, duration of oral contr
1706associated with higher risks of cataracts treated surgically. However,
after adjustment for other factors, there was no association with
education, and the association with deprivation was attenuated.
Table 3 shows the RR of cataracts treated surgically by
reproductive history and use of hormonal therapies. There wereh Various Socioeconomic Factors, Lifestyle Factors, and Diabetes
ses
RR (95% CI)
Minimally Adjusted*
RR (95% CI)
Multiply Adjustedy
388 1.00 1.00
751 1.04 (1.02e1.07) 1.03 (1.00e1.05)
451 1.10 (1.08e1.13) 1.07 (1.04e1.09)
447 1.18 (1.16e1.21) 1.11 (1.09e1.13)
654 1.38 (1.35e1.41) 1.22 (1.22e1.25)
481 1.00 1.00
299 1.01 (0.98e1.03) 0.98 (0.96e1.01)
983 1.04 (1.01e1.07) 0.99 (0.96e1.02)
657 1.17 (1.14e1.19) 1.02 (0.99e1.04)
007 1.00 1.00
211 1.13 (1.11e1.14) 1.10 (1.08e1.12)
318 1.15 (1.13e1.18) 1.12 (1.09e1.14)
859 1.35 (1.32e1.39) 1.26 (1.23e1.30)
589 1.00 1.00
821 1.06 (1.05e1.08) 1.02 (1.01e1.04)
645 1.30 (1.27e1.32) 1.12 (1.10e1.14)
447 1.00 1.00
331 0.86 (0.85e0.87) 0.93 (0.91e0.94)
613 0.87 (0.83e0.89) 0.92 (0.89e0.96)
960 1.00 1.00
177 0.83 (0.82e0.84) 0.90 (0.88e0.91)
589 1.00 1.00
671 3.15 (3.07e3.23) 2.90 (2.82e2.97)
educational attainment, smoking, BMI, alcohol intake, strenuous physical
aceptive use, and HT use as appropriate.
Table 3. Relative Risk of Cataracts Treated Surgically Associated with Reproductive History and Use of Hormonal Therapies
Population at Risk Cases
RR (95% CI)
Minimally Adjusted*
RR (95% CI)
Multiply Adjustedy
Age at menarche
12 yrs 489 916 32 190 1.00
13 yrs 312 596 20 354 0.93 (0.92e0.95) 0.96 (0.95e0.98)
14 yrs 264 093 18 189 0.94 (0.93e0.96) 0.96 (0.94e0.98)
15þ yrs 218 444 16 634 0.99 (0.97e1.01) 0.99 (0.97e1.01)
Parity
Nulliparous 141 538 10 291 1.00 1.00
Parous 1 168 265 78 838 0.94 (0.92e0.96) 0.92 (0.90e0.94)
No. of childrenz
1 185 571 13 178 1.00 1.00
2 550 543 33 614 0.92 (0.90e0.94) 0.96 (0.94e0.98)
3 282 728 19 341 0.95 (0.93e0.97) 0.95 (0.93e0.97)
4þ 149 423 12 705 1.06 (1.03e1.08) 0.98 (0.95e1.00)
Duration of oral contraceptive use
Never 527 767 45 956 1.00 1.00
<5 yrs 308 821 17 207 1.01 (0.99e1.02) 1.03 (1.01e1.05)
5þ yrs 428 712 22 350 0.98 (0.96e0.99) 1.00 (0.99e1.02)
HT use
Never 643 484 46 799 1.00 1.00
Ever 652 768 41 053 1.04 (1.02e1.05) 1.07 (1.06e1.09)
CI ¼ conﬁdence interval; HT ¼ hormone therapy; RR ¼ relative risk.
*Estimates of RR are adjusted by age and region of residence.
yEstimates of RR are adjusted by age and region of residence plus deprivation, educational attainment, smoking, BMI, alcohol, strenuous physical activity,
treatment for diabetes, age at menarche, parity, duration of oral contraceptive use, and HT use as appropriate.
zIn 1 168 265 women who had had at least 1 child.
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according to age at menarche or use of oral contraceptives.
Parous women seemed to be slightly less likely to undergo
cataract surgery than nulliparous women, but there was no
evidence for a trend in risk by number of children among parous
women. Ever users of HT at recruitment were slightly more
likely than never users to undergo surgery for cataract (multiply
adjusted RR, 1.07; 95% CI, 1.06e1.09). In analyses looking at
risk in relation to HT type (in 1 228 856 women; 6 444 986 total
follow-up years), current users of estrogen-only HT had an RR
of 1.08 (95% CI, 1.04e1.13) for cataracts treated surgically, and
current users of estrogen-progestogen HT had an RR of 1.02 (95%
CI, 0.98e1.07).
Discussion
In this large prospective study of postmenopausal women,
previously reported associations between both diabetes and
smoking and an increased risk of cataracts were conﬁrmed.
There was also evidence of an increased risk for obese
women. Physical activity, alcohol intake, reproductive
factors, and hormonal factors had little, if any, association
with cataracts treated surgically: the RRs were small in
magnitude, and the effect of residual confounding cannot be
ruled out.
Diabetes and Lifestyle Factors and Risk of
Cataracts Treated Surgically
Previous research has shown that cataracts develop at an
earlier age in people with diabetes.3,21,22 The pathogenesisof cataracts in diabetic individuals is not fully under-
stood.3,23 Lifestyle factors that have been identiﬁed as risk
factors for cataracts are smoking and UV light exposure,
both of which are thought to affect cataract formation
through oxidation.4,5,24e26 In addition, the use of cortico-
steroids, both systemic and inhaled, has been identiﬁed as a
risk factor for cataract formation.2,6,7 This study did not
have information on UV light exposure or use of cortico-
steroids at baseline, but our results for smoking conﬁrm the
higher risks found in other studies.24e26 Our results also
provide further conﬁrmatory evidence that there is an
increased risk of cataracts in past smokers as well as in
current smokers.24
Two recent meta-analyses have examined the relation-
ship between alcohol intake and the risk of cataract or cat-
aracts treated surgically.27,28 The ﬁrst meta-analysis in 2014
of 7 prospective cohort studies did not ﬁnd alcohol to be a
statistically signiﬁcant risk factor for cataract surgery or
cataracts.28 The second meta-analysis in 2015 of 5 pro-
spective studies and 5 case-control studies reported a
borderline increased risk of cataracts for heavy alcohol
consumption (classiﬁed as >14 units per week), but con-
founding by smoking was seen.27 We did not ﬁnd a clearly
increased risk of cataracts treated surgically related to heavy
alcohol consumption, but there are few heavy alcohol
drinkers in this cohort. The slight decreased risk in our
study for moderate alcohol consumption is consistent with
the previous evidence of a lack of association.27,28
We found evidence that obesity (BMI 30 kg/m2) may
weakly increase the risk of cataracts treated surgically,
but there was no increased risk related to overweight1707
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analysis of 6 prospective studies that showed that the
development of all types of cataract (nuclear, cortical, or
posterior subcapsular) was associated with obesity.29 It is
unclear how much of the association with obesity is due
to clinical or subclinical diabetes.4,8e10,29 However, when
women who reported treatment for diabetes were excluded,
the association we found between BMI and cataracts treated
surgically did not change, which suggests that obesity may
be an independent risk factor.
Previous evidence on the potential effect of physical
activity is sparse, with only 3 prospective studies having
been carried out,30,31 and only 1 in the general population.32
The evidence from our study of a slightly lower risk
associated with doing some strenuous physical activity
agrees with previous evidence. However, this lower risk
associated with physical activity could be due to reverse
causation bias, because women with cataracts might be
less likely to participate in strenuous physical activity
because of visual impairment.
Hormonal and Reproductive Factors and Risk of
Cataracts Treated Surgically
A recent meta-analysis of 4 prospective cohort studies
concluded that use of HT for menopause was associated
with a decreased risk of diagnosed cataract for ever users
(pooled OR, 0.83; 95% CI, 0.71e0.97 compared with never
users).16 In contrast, a prospective study from Sweden, with
more than 30 000 women and 4324 cataract surgery cases,
not included in the meta-analysis, found that HT use was
associated with an increase in risk of cataracts treated sur-
gically (RR, 1.14; 95% CI, 1.07e1.21 for ever users
compared with never users).17 In our multiply adjusted
analyses, ever users of HT at recruitment were slightly
more likely than never users to undergo surgery for
cataract (RR, 1.07; 95% CI, 1.06e1.09), with no material
difference in risk between users of estrogen-only and
estrogen-progestogen HT. These ﬁndings should be inter-
preted with caution because such small increases (or
decreases) in RR may well reﬂect residual confounding. The
present results suggest that a strong relationship between HT
use and cataracts is unlikely.
Few other studies have investigated the association of
reproductive factors with cataracts, and these have had
mixed results.33e35 We found no evidence to support a role
of the reproductive factors studied (age at menarche and
parity) in relation to risk of cataracts treated surgically;
while a statistically signiﬁcant reduction in risk was found
for parous compared with nulliparous women, there was no
evidence for a trend in risk by number of children among
parous women, and, again, residual confounding could well
explain a small apparent association.
Study Strengths and Limitations
The strengths of this study are the large sample size and the
long average follow-up period of 11 years. This is the
largest single study examining risk factors for cataracts
treated surgically. With approximately one quarter of
eligible women in the United Kingdom participating in the1708Million Women Study and the power to examine risk factors
across a full range of population values, the study can be
considered representative of the UK population of middle-
aged women. The incidence rates of cataract surgery (6.38
per 1000) are similar to those reported for the whole UK
population in 200411 (6.37 per 1000). The inclusion of
socioeconomic, lifestyle, reproductive, and hormonal
factors, as well as treatment for diabetes, enabled us to
adjust for many risk factors at the same time. The use of
linked routinely collected health records of cataract
surgery as the end point of interest is both a
strengthdallowing near-complete, unbiased, long-term,
cost-effective follow-up in a large cohortdand a limita-
tion, in that hospital records provide limited information on
clinical details such as type of cataract and extent of visual
loss.
In general, the majority of surgeries in the United
Kingdom are performed within the NHS,36 but some women
in the cohort may have undergone privately funded cataract
surgery outside the NHS and therefore would not be
identiﬁed by the record linkage to NHS data. In 1997 and
1998, an estimated 14% of lens operations in England and
Wales were privately funded and carried out in private
hospitals.36 This estimate predates follow-up for this study,
but we are not aware of more recent estimates. Misclassiﬁ-
cation of cases is unlikely to have had a substantial effect on
power to detect risk factor associations, but, together with
residual confounding, this could account for the association
between deprivation and cataracts treated surgically.
The risk factor associations identiﬁed in the current
article in relation to surgery for cataracts may not be iden-
tical to those related to the development of cataract;
although minimally invasive surgery for cataract is widely
available in the United Kingdom, comorbidities that may be
related to the risk factors studied are likely to affect uptake
of surgery. For example, cataract surgery can be performed
to assist the management of other eye conditions, such as
diabetic retinopathy.37 However, our ﬁndings for diabetes
and smoking are consistent with previous studies of both
cataract21,24,38 and surgery for cataract.22,24,25
In conclusion, cataracts are the second leading cause of
partial sight and blindness in the United Kingdom, and
cataract surgery is the most common operation performed in
the United Kingdom. Therefore, it is important to identify
any risk factors that may be modiﬁable. For the women in
this large prospective cohort study in the United Kingdom,
diabetes and smoking were associated with a higher risk of
undergoing cataract surgery. There was also evidence of a
small increase in risk for obese women. Alcohol use,
physical activity, reproductive history, and use of hormonal
therapies had little, if any, association with cataract surgery
risk.
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